Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-9-23
pubmed:abstractText
Growth hormone (GH) transgenic mice are known to develop hepatocellular adenomas and carcinomas. In order to understand more about hepatocarcinogenesis in the GH-transgenic mouse model we quantitated the rates of hepatocellular proliferation and apoptosis in these mice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0106-9543
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
242-52
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10395045-Adenoma, pubmed-meshheading:10395045-Age Factors, pubmed-meshheading:10395045-Animals, pubmed-meshheading:10395045-Apoptosis, pubmed-meshheading:10395045-Body Weight, pubmed-meshheading:10395045-Carcinoma, Hepatocellular, pubmed-meshheading:10395045-Cell Division, pubmed-meshheading:10395045-Female, pubmed-meshheading:10395045-Growth Hormone, pubmed-meshheading:10395045-In Situ Nick-End Labeling, pubmed-meshheading:10395045-Liver, pubmed-meshheading:10395045-Liver Neoplasms, Experimental, pubmed-meshheading:10395045-Male, pubmed-meshheading:10395045-Metallothionein, pubmed-meshheading:10395045-Mice, pubmed-meshheading:10395045-Mice, Inbred C57BL, pubmed-meshheading:10395045-Mice, Transgenic, pubmed-meshheading:10395045-Mitotic Index, pubmed-meshheading:10395045-Organ Size
pubmed:year
1999
pubmed:articleTitle
High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice.
pubmed:affiliation
Centre for Animal Biotechnology, School of Veterinary Science, The University of Melbourne, Parkville, Victoria, Australia.
pubmed:publicationType
Journal Article